Home Pilots Home allergy testing company Nectar secures $16.5M in funding Pilots Home allergy testing company Nectar secures $16.5M in funding By - December 20, 2022 40 0 Facebook Twitter Pinterest WhatsApp The investment will support the company’s growth nationwide, fund clinical trials and open a physical location. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Layer Health launches with $4M from Google Ventures, General Catalyst Pilots - November 22, 2023 0 New online platform for doctors launches in India Pilots - January 11, 2022 0 Trialjectory scores $20M to match cancer patients to clinical trials Pilots - February 7, 2022 0 Medable snaps up dermatology-focused Omhu A/S Pilots - February 2, 2022 0 Roundup: PatientSource solution eliminates manual data gathering at Israeli hospital, Florence raises £28.5M to... Pilots - June 2, 2022 0 POPULAR CATEGORIESPilots2166Applications750Testing283Collaborations15GitHub3